Disease Management
Nov 26, 2015
Transthyretin (TTR) amyloidosis (ATTR amyloidosis) is a multisystemic, multigenotypic disease resulting from deposition of insoluble ATTR amyloid fibrils in various…
Oct 22, 2015
Systemic amyloidoses are rare, complex diseases caused by misfolding of autologous protein. The presence of heart involvement is the most important prognostic…
Sep 14, 2015
Amyloidosis is a disease in which proteins misfold, aggregate into fibrils, and deposit extracellularly disrupting organ architecture and function. There are two…
Principles of treatmentTreatment of all types of amyloidosis is currently based on the following principles:Reducing the supply of amyloid forming precursor…
AA amyloidosis, or secondary amyloidosis, is one type of the rare disorder amyloidosis. This disorder happens when proteins in your body mutate, changing form and…
Rare diseases present unique challenges, often beginning with a diagnosis. Symptoms may puzzle patients and even leave health care providers uncertain. Diagnostic…
Amyloidosis is a serious condition in which a protein known as amyloidosis is accumulated in various parts of the body leading to various complications. Treatment…
Founded in 1974, the Association of Black Cardiologists, Inc., (ABC) is a nonprofit organization with an international membership of 2,500 health professionals, lay…
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide…
The FDA today granted Alnylam Pharmaceuticals approval for a first-in-class small interfering ribonucleic acid (siRNA) treatment-the first therapy indicated for…